Fumiko Saito-Ohara

PPM1D is a potential target for 17q gain in neuroblastoma.

Fumiko Saito-Ohara, Issei Imoto, Jun Inoue et al. · PubMed · 2003 · 232 citations

Medicine, Genetics, Molecular Genetics +14

Alteration in Copy Numbers of Genes as a Mechanism for Acquired Drug Resistance

Kohichiroh Yasui, Saori Mihara, Chen Zhao et al. · Cancer Research · 2004 · 220 citations

Medicine, Genetics, Oncology +17

The Novel Gene Encoding a Putative Transmembrane Protein Is Mutated in Gnathodiaphyseal Dysplasia (GDD)

Satoshi Tsutsumi, Nobuyuki Kamata, Tamara Vokes et al. · The American Journal of Human Genetics · 2004 · 175 citations · Full text

Life Sciences, Genetics, Molecular Genetics +6

Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets.

Akira Hirasawa, Fumiko Saito-Ohara, Jun Inoue et al. · PubMed · 2003 · 170 citations

Medicine, Genetics, Oncology +17

A Novel Target Gene, SKP2, within the 5p13 Amplicon That Is Frequently Detected in Small Cell Lung Cancers

Sana Yokoi, Kohichiroh Yasui, Fumiko Saito-Ohara et al. · American Journal Of Pathology · 2002 · 170 citations · Full text

Medicine, Genetics, Oncology +11